Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 28:11:1429783.
doi: 10.3389/fmed.2024.1429783. eCollection 2024.

Association of obstructive sleep apnea syndrome with polycystic ovary syndrome through bidirectional Mendelian randomization

Affiliations

Association of obstructive sleep apnea syndrome with polycystic ovary syndrome through bidirectional Mendelian randomization

Peijun Liu et al. Front Med (Lausanne). .

Abstract

Background: Observational studies have established a link between polycystic ovary syndrome (PCOS) and obstructive sleep apnea syndrome (OSAS), with obesity being a significant confounding factor that complicates the understanding of causality. This study seeks to clarify the causal relationship by utilizing bidirectional two-sample Mendelian randomization (MR) analysis.

Methods: A bidirectional MR strategy was implemented to investigate the potential causal relationship between PCOS and OSAS. Instrumental variables (IVs) for PCOS were sourced from a dataset comprising 3,609 cases and 229,788 controls. For OSAS, statistical data were obtained from a genome-wide association study (GWAS) involving 38,998 subjects, alongside a control group of 336,659 individuals. Our MR analysis utilized several methods, including inverse variance weighted (IVW), weighted mode, weighted median, simple mode, and MR-Egger, primarily focusing on the IVW technique. Sensitivity tests were conducted to ensure the robustness of our findings.

Results: Utilizing the IVW method, we identified a notable causal association from OSAS to PCOS, with an odds ratio (OR) of 1.463 and a 95% confidence interval (CI) of 1.086-1.971 (p = 0.012). In the opposite direction, PCOS also appeared to significantly affect OSAS development, indicated by an OR of 1.041 and a 95% CI of 1.012-1.072 (p = 0.006). The MR-Egger intercept test showed no evidence of directional pleiotropy, affirming the credibility of our causal findings (p > 0.05).

Conclusion: This study suggests a bidirectional causal relationship between PCOS and an increased risk of OSAS. These insights could guide future screening and prevention strategies for both conditions.

Keywords: GWAS; Mendelian randomization; OSAS; PCOS; causal inference.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Schematic illustration showing the two-way Mendelian Randomization method employed to investigate the causal connection between PCOS and OSAS. PCOS, Polycystic ovary syndrome; OSAS, Obstructive sleep apnea syndrome.
Figure 2
Figure 2
Depicts MR studies on the causal link with OSAS as the predictor and PCOS as the result. (A) Shows the causative influence of OSAS on PCOS. (B) A scatter diagram showing the analysis of individual SNPs to assess OSAS effect on the likelihood of PCOS. (C) A graph excluding one genetic variant shows the combined impact of SNPs on the link connecting OSAS with PCOS.
Figure 3
Figure 3
MR evaluations reveal causal relationships, with PCOS predicting OSAS the consequence. (A) Details the causative effect of PCOS on OSAS. (B) A scatter diagram examines the SNPs to understand how PCOS affects the onset OSAS. (C) A leave one out graph underscores the collective effects of SNPs and their impact link connecting PCOS and OSAS.

Similar articles

Cited by

References

    1. Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril. (2018) 110:364–79. doi: 10.1016/j.fertnstert.2018.05.004, PMID: - DOI - PMC - PubMed
    1. Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol. (2011) 7:219–31. doi: 10.1038/nrendo.2010.217 - DOI - PubMed
    1. Nitsche K, Ehrmann DA. Obstructive sleep apnea and metabolic dysfunction in polycystic ovary syndrome. Best Pract Res Clin Endocrinol Metab. (2010) 24:717–30. doi: 10.1016/j.beem.2010.08.001, PMID: - DOI - PMC - PubMed
    1. Senaratna CV, Perret JL, Lodge CJ, Lowe AJ, Campbell BE, Matheson MC, et al. Prevalence of obstructive sleep apnea in the general population: a systematic review. Sleep Med Rev. (2017) 34:70–81. doi: 10.1016/j.smrv.2016.07.002 - DOI - PubMed
    1. Korkalainen H, Töyräs J, Nikkonen S, Leppänen T. Mortality-risk-based apnea-hypopnea index thresholds for diagnostics of obstructive sleep apnea. J Sleep Res. (2019) 28:e12855. doi: 10.1111/jsr.12855, PMID: - DOI - PubMed

LinkOut - more resources